Veraxa Biotech director Christoph Samuel Ziegler reports $32,700 common share acquisition
VRXA•Veraxa Biotech director Christoph Samuel Ziegler purchased 30,000 ordinary shares at $1.09 each, increasing his direct holdings to 37,932 shares.
1. Share purchase
Christoph Samuel Ziegler purchased 30,000 Veraxa Biotech ordinary shares at $1.09 each. His direct holdings rose to 37,932 ordinary shares.
